ANEUVO Launches US Study of ExaStim, a Non-invasive Spinal
Los Angeles, CA, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Los Angeles. – February 2, 2023 – Today, ANEUVO, a platform and
Globe Newswire2-02-2023, 22:36
Junshi Biosciences Announces Toripalimab in Combination with Chemotherapy for Treatment of Advanced Triple-negative Breast Cancer Met Primary Endpoint in Phase 3 Clinical Study 21-02-2023, 10:53